Allogeneic peripheral blood stem cell

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	8

65. 原発性免疫不全症候群

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 8 of 8 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04965597 (ClinicalTrials.gov)	April 19, 2022	21/6/2021	Treosulfan-Based Conditioning Regimen Before a Bloodor Bone Marrow Transplant for the Treatment of B ...	Hematopoietic CellTransplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marr ...	Bone Marrow Failure Syndrome;Congenital Amegakaryocytic Thrombocytopenia;Congenital Pure Red CellApl ...	Drug: Treosulfan;Drug: Fludarabine Phosphate;Drug: Tacrolimus;Drug: Methotrexate;Biological: Lapine ...	Fred Hutchinson Cancer Center	Bloodand Marrow Transplant Clinical Trials Network;National Cancer Institute (NCI);National Marrow D ...	Recruiting	1 Year	49 Years	All	40	Phase 2	United States
2	NCT03910452 (ClinicalTrials.gov)	October 28, 2019	9/4/2019	Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Bus ...	Haploidentical Transplant for Patients With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, B ...	Chronic Granulomatous Disease	Drug: Busulfan;Drug: Alemtuzumab;Drug: Cyclophosphamide;Drug: Sirolimus;Radiation: Total Body Irradi ...	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Recruiting	4 Years	65 Years	All	30	Early Phase 1	United States
3	NCT03333486 (ClinicalTrials.gov)	December 7, 2017	2/11/2017	Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem CellTransplant in Tr ...	A Phase II Trial of Haploidentical Allogeneic Stem CellTransplantation Utilizing Mobilized Periphera ...	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Acute Leukemia in Remission;Acute ...	Drug: Cyclophosphamide;Drug: Fludarabine Phosphate;Other: Laboratory Biomarker Analysis;Procedure: P ...	Roswell Park Cancer Institute	NULL	Active, not recruiting	1 Year	75 Years	All	31	Phase 2	United States
4	NCT01529827 (ClinicalTrials.gov)	February 28, 2012	6/2/2012	Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral B ...	A Phase II Trial of Reduced Intensity Allogeneic Stem CellTransplantation With Fludarabine, Melphala ...	Accelerated Phase Chronic Myelogenous Leukemia;Adult Acute Lymphoblastic Leukemia in Remission;Adult ...	Drug: fludarabine phosphate;Drug: melphalan;Radiation: total-body irradiation;Drug: tacrolimus;Drug: ...	Roswell Park Cancer Institute	NULL	Completed	3 Years	75 Years	All	94	Phase 2	United States
5	NCT02512679 (ClinicalTrials.gov)	February 2007	21/5/2015	Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells	Protocol for Related Donor Hematopoietic Stem CellTransplantation (HSCT) for Treatment of Symptomati ...	Stem CellTransplantation;Bone Marrow Transplantation;Peripheral Blood Stem CellTransplantation;Allog ...	Drug: Cyclophosphamide Dose Level 1;Drug: Cyclophosphamide Dose Level 2;Drug: Cyclophosphamide Dose ...	Children's Hospital Los Angeles	Lucile Packard Children's Hospital	Terminated	3 Months	N/A	All	20	Phase 2	NULL
6	NCT00295971 (ClinicalTrials.gov)	April 2005	23/2/2006	Donor Stem CellTransplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone M ...	Stem CellEnriched, T CellDepleted Haplocompatible Peripheral BloodTransplantation for Children With ...	Congenital Amegakaryocytic Thrombocytopenia;Leukemia;Myelodysplastic Syndromes;Severe Congenital Neu ...	Biological: anti-thymocyte globulin;Biological: therapeutic allogeneiclymphocytes;Drug: fludarabine ...	University of California, San Francisco	National Cancer Institute (NCI)	Completed	1 Year	17 Years	Both	21	Phase 1	United States
7	NCT00301834 (ClinicalTrials.gov)	January 2005	9/3/2006	Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem CellTransplant in Treating Young Patie ...	Evaluation of Fludarabine, Busulfan and Alemtuzumab as a Reduced Toxicity Ablative Bone Marrow Stem ...	Congenital Amegakaryocytic Thrombocytopenia;Diamond-blackfan Anemia;Leukemia;Myelodysplastic Syndrom ...	Biological: alemtuzumab;Drug: busulfan;Drug: cyclosporine;Drug: fludarabine phosphate;Drug: methotre ...	University of California, San Francisco	National Cancer Institute (NCI)	Completed	N/A	21 Years	All	35	Phase 2	United States
8	NCT00305708 (ClinicalTrials.gov)	August 2000	21/3/2006	Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem CellTransplant in Treatin ...	Bone Marrow Stem CellTransplantation for Children With Stem CellDefects, Marrow Failure Syndromes, o ...	Congenital Amegakaryocytic Thrombocytopenia;Diamond-blackfan Anemia;Fanconi Anemia;Leukemia;Severe C ...	Biological: anti-thymocyte globulin;Drug: busulfan;Drug: fludarabine phosphate;Procedure: allogeneic ...	University of California, San Francisco	National Cancer Institute (NCI)	Completed	N/A	17 Years	Both	40	Phase 1/Phase 2	United States

First Previous1Next Last